The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.
about
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndromePrevalence of irritable bowel syndrome: a community survey.Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional SyndromesEffect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysisDietary triggers in irritable bowel syndrome: Is there a role for glutenDiagnosis and management of functional symptoms in inflammatory bowel disease in remissionPsychosocial impact of irritable bowel syndrome: A brief reviewDiet in irritable bowel syndromeConducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team reportOverlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndromeDietary agents and phytochemicals in the prevention and treatment of experimental ulcerative colitisMelatonin for the treatment of irritable bowel syndromeReview article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel diseaseVisceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteasesBarriers to accurate diagnosis and effective management of heart failure have not changed in the past 10 years: a qualitative study and national survey.Mechanisms and efficacy of dietary FODMAP restriction in IBS.Treatments for irritable bowel syndrome: patients' attitudes and acceptabilityFunctional Constipation and Constipation-Predominant Irritable Bowel Syndrome in the General Population: Data from the GECCO StudyDevelopment and psychometric testing of the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS).Evaluation of the Birmingham IBS symptom questionnaireFrom comic relief to real understanding; how intestinal gas causes symptomsComparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS).Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome.Subtypes and Symptomatology of Irritable Bowel Syndrome in Children and Adolescents: A School-based Survey Using Rome III Criteria.Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway.Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.Colonic gas transit in patients with bloating: the effect of an electromechanical stimulator of the abdominal wall.A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome.The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.Association between symptoms of irritable bowel syndrome and methane and hydrogen on lactulose breath testDoes oral α-galactosidase relieve irritable bowel symptoms?Dietary fiber in irritable bowel syndrome (Review)Comparing administrative and survey data for ascertaining cases of irritable bowel syndrome: a population-based investigation.How does comorbidity affect cost of health care in patients with irritable bowel syndrome? A cohort study in general practice.Estimating the burden of irritable bowel syndrome: analysis of a nationwide korean database.A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndromePrevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women.Irritable bowel syndrome is concentrated in people with higher educations in Iran: an inequality analysisComparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome.
P2860
Q24234934-FA70537C-DD60-47DD-B007-123155716041Q24535897-85CF0082-6D47-4F69-8A72-0930991FF0B9Q24601623-31E2D740-3CE6-4093-B533-0B3B10DFDED9Q24656989-A271A28D-A32C-4159-BECA-036C8031F863Q26739974-93AB1EE5-9B56-46F4-94CF-4EED4969BD62Q26768264-3A19C66F-E954-4984-9D6A-D50228CA886AQ26776175-CAEA4C3B-B436-4361-9162-0EA3974E4AF6Q26824367-97DE6CF2-E829-4FD0-91F5-17CF67BE9F09Q26827089-0854B097-C773-415E-9DB3-1464C6F0DBDEQ27008998-295F5E53-2103-48A2-825D-B7DAE4039167Q27021100-7180AA9F-08EB-4AB1-BF80-AFCE7EE52A7EQ27027366-EDD436C1-77C3-4245-8278-062575BEEF4AQ28083764-0CD2EC59-F5B0-4222-AC07-B8DA3D114D5AQ28818844-9637F1A8-4E65-44E4-AFCB-3AEBC6AB81CBQ30575444-A7B5C665-D042-43FF-B423-CA517B0EDB09Q30738587-C132EFB6-9641-4418-9D53-18FC3BE08A3AQ30855641-7E3462D1-260A-416C-A46C-4E5C4E169510Q31046205-456D34E9-BE9C-4EF9-8B19-3738946AF238Q33283471-A609EFB6-DA96-47CB-8404-002BDC0ED483Q33354600-724C2181-F999-42E4-919A-54184BF0FAB0Q33430635-3B65E261-EE28-4430-9598-0ECB01DA4B99Q33450566-2CA6C2F8-479D-40FE-8F6F-9F1BCC57C31DQ33452388-9F3580B9-1AD5-4103-805E-4A2D8C3399B2Q33454969-EFF48BDF-9043-4D04-B707-7E7AA37971C0Q33455352-F63CE5BE-CEDA-4F72-8CBC-AF068586189AQ33456089-5712E29A-2E15-4591-8596-19C15BBCDF97Q33456102-90950271-C803-45DE-97BF-B1649165F589Q33456557-0ABE8375-1110-4316-949D-457D6E9A57FDQ33457416-E1A92C14-5487-4AFA-9D37-A9ED913457C8Q33458071-1A075677-E5C3-45E6-A378-D027B0C3187BQ33458349-CAC7AEB7-F95A-4FC5-BF7A-D5293A4DE129Q33465479-06F4F325-9477-4484-869F-3561EF76FEC7Q33470938-E14D25DF-63C6-4CEF-875C-59697199E36DQ33527597-61A97476-813A-4691-98BA-DE58A7627109Q33541333-8668FE8B-867A-4863-B3DC-8CB9852DA46FQ33586874-B13D75D3-E700-4B04-815C-84357FB8718CQ33629410-FC885727-8F33-499A-BC40-BCAF5EF54847Q33650356-E3399D48-61B2-4A1D-BA61-8BE2662806F3Q33695553-0586F30E-CB9C-484F-A095-BD196082133CQ33781168-9BC01065-6D11-4F97-BD90-A598E5C90D3A
P2860
The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The prevalence, patterns and i ...... nal survey of 40,000 subjects.
@en
The prevalence, patterns and i ...... nal survey of 40,000 subjects.
@nl
type
label
The prevalence, patterns and i ...... nal survey of 40,000 subjects.
@en
The prevalence, patterns and i ...... nal survey of 40,000 subjects.
@nl
prefLabel
The prevalence, patterns and i ...... nal survey of 40,000 subjects.
@en
The prevalence, patterns and i ...... nal survey of 40,000 subjects.
@nl
P2093
P1476
The prevalence, patterns and i ...... nal survey of 40,000 subjects.
@en
P2093
P304
P356
10.1046/J.1365-2036.2003.01456.X
P407
P577
2003-03-01T00:00:00Z